Analysis of Therapeutic Oligonucleotides by UHPSEC-MALS

The oligonucleotide therapeutics field has seen remarkable progress over the last few years and oligonucleotides are increasingly recognized as potential therapeutic agents for a variety of diseases. Ultra-high performance size-exclusion chromatography can be used to analyze size heterogeneity of oligonucleotides

contributed by Tosoh | 02/07/2020

A new application note describes the ability of size-exclusion chromatography to discriminate oligonucleotides differing by one base in length when using UHPLC or UHPLC-MALS. For this purpose, a new silica gel-based phase, TSKgel UPSW2000, with a pore size of 12.5 nm was applied, which is also perfectly suited for the analysis of smaller proteins and peptide aggregates.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.